(OWLT) Owlet - Overview
Stock: Sock Monitor, Video Monitor, Subscription, Accessories
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 77.5% |
| Relative Tail Risk | -12.8% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.42 |
| Alpha | 121.02 |
| Character TTM | |
|---|---|
| Beta | 1.120 |
| Beta Downside | 1.906 |
| Drawdowns 3y | |
|---|---|
| Max DD | 59.42% |
| CAGR/Max DD | 0.56 |
Description: OWLT Owlet January 17, 2026
Owlet Inc. (NYSE: OWLT) develops and sells a suite of digital parenting products, including the Dream Sock and Owlet Smart Sock wearable monitors that track infants’ heart rate, oxygen saturation, activity and sleep, as well as the Owlet Cam video/audio monitor. The hardware is integrated into the Owlet Care app, which aggregates real-time data and offers analytics through the Owlet360 subscription service. The company operates in the United States, United Kingdom and other international markets, and is classified under the Health Care Equipment sub-industry.
Key recent metrics (as of FY 2024 Q3) show revenue of $112 million, up ~28 % YoY, driven by a 42 % increase in subscription-based recurring revenue, which now represents roughly 19 % of total sales. Gross margin has expanded to 58 % after cost-optimization of the wearable sensor supply chain. The infant health-tech market is projected to grow at a 9 % CAGR through 2028, supported by rising parental spending on connected health devices and the broader tele-health adoption trend accelerated by the pandemic.
If you want a deeper quantitative assessment of Owlet’s valuation dynamics, a quick look at ValueRay’s analyst framework could be a useful next step.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: -38.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.10 > 0.02 and ΔFCF/TA 20.00 > 1.0 |
| NWC/Revenue: 8.73% < 20% (prev 21.11%; Δ -12.38% < -1%) |
| CFO/TA -0.09 > 3% & CFO -7.02m > Net Income -38.2m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 1.14 > 1.5 & < 3 |
| Outstanding Shares: last quarter (15.7m) vs 12m ago 42.32% < -2% |
| Gross Margin: 52.06% > 18% (prev 0.49%; Δ 5158 % > 0.5%) |
| Asset Turnover: 152.2% > 50% (prev 140.0%; Δ 12.16% > 0%) |
| Interest Coverage Ratio: -8.38 > 6 (EBITDA TTM -34.6m / Interest Expense TTM 4.21m) |
Altman Z'' -15.00
| A: 0.12 (Total Current Assets 71.6m - Total Current Liabilities 62.9m) / Total Assets 74.9m |
| B: -3.99 (Retained Earnings -298.7m / Total Assets 74.9m) |
| C: -0.54 (EBIT TTM -35.2m / Avg Total Assets 65.5m) |
| D: -2.59 (Book Value of Equity -294.3m / Total Liabilities 113.5m) |
| Altman-Z'' Score: -18.58 = D |
Beneish M -3.31
| DSRI: 1.31 (Receivables 28.6m/17.2m, Revenue 99.7m/78.6m) |
| GMI: 0.93 (GM 52.06% / 48.64%) |
| AQI: 0.59 (AQ_t 0.04 / AQ_t-1 0.06) |
| SGI: 1.27 (Revenue 99.7m / 78.6m) |
| TATA: -0.42 (NI -38.2m - CFO -7.02m) / TA 74.9m) |
| Beneish M-Score: -3.31 (Cap -4..+1) = AA |
What is the price of OWLT shares?
Over the past week, the price has changed by -7.27%, over one month by -29.12%, over three months by +18.60% and over the past year by +135.71%.
Is OWLT a buy, sell or hold?
- StrongBuy: 3
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the OWLT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 17 | 51.5% |
| Analysts Target Price | 17 | 51.5% |
| ValueRay Target Price | 10.4 | -7.8% |
OWLT Fundamental Data Overview February 05, 2026
P/B = 12.2156
Revenue TTM = 99.7m USD
EBIT TTM = -35.2m USD
EBITDA TTM = -34.6m USD
Long Term Debt = 2.92m USD (from longTermDebt, last quarter)
Short Term Debt = 22.0m USD (from shortTermDebt, last quarter)
Debt = 24.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.19m USD (from netDebt column, last quarter)
Enterprise Value = 356.9m USD (355.7m + Debt 24.9m - CCE 23.8m)
Interest Coverage Ratio = -8.38 (Ebit TTM -35.2m / Interest Expense TTM 4.21m)
EV/FCF = -47.50x (Enterprise Value 356.9m / FCF TTM -7.51m)
FCF Yield = -2.11% (FCF TTM -7.51m / Enterprise Value 356.9m)
FCF Margin = -7.54% (FCF TTM -7.51m / Revenue TTM 99.7m)
Net Margin = -38.36% (Net Income TTM -38.2m / Revenue TTM 99.7m)
Gross Margin = 52.06% ((Revenue TTM 99.7m - Cost of Revenue TTM 47.8m) / Revenue TTM)
Gross Margin QoQ = 50.64% (prev 51.25%)
Tobins Q-Ratio = 4.77 (Enterprise Value 356.9m / Total Assets 74.9m)
Interest Expense / Debt = 3.45% (Interest Expense 860.0k / Debt 24.9m)
Taxrate = 0.22% (9000 / 4.14m)
NOPAT = -35.2m (EBIT -35.2m * (1 - 0.22%)) [loss with tax shield]
Current Ratio = 1.14 (Total Current Assets 71.6m / Total Current Liabilities 62.9m)
Debt / Equity = -0.65 (negative equity) (Debt 24.9m / totalStockholderEquity, last quarter -38.6m)
Debt / EBITDA = -0.03 (negative EBITDA) (Net Debt 1.19m / EBITDA -34.6m)
Debt / FCF = -0.16 (negative FCF - burning cash) (Net Debt 1.19m / FCF TTM -7.51m)
Total Stockholder Equity = -30.2m (last 4 quarters mean from totalStockholderEquity)
RoA = -58.37% (Net Income -38.2m / Total Assets 74.9m)
RoE = 126.8% (negative equity) (Net Income TTM -38.2m / Total Stockholder Equity -30.2m)
RoCE = 129.5% (negative capital employed) (EBIT -35.2m / Capital Employed (Equity -30.2m + L.T.Debt 2.92m))
RoIC = 175.2% (negative operating profit) (NOPAT -35.2m / Invested Capital -20.1m)
WACC = 9.61% (E(355.7m)/V(380.6m) * Re(10.04%) + D(24.9m)/V(380.6m) * Rd(3.45%) * (1-Tc(0.00)))
Discount Rate = 10.04% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 36.24%
Fair Price DCF = unknown (Cash Flow -7.51m)
EPS Correlation: -17.41 | EPS CAGR: 2.94% | SUE: -0.30 | # QB: 0
Revenue Correlation: 55.05 | Revenue CAGR: 118.5% | SUE: 1.44 | # QB: 4
EPS next Quarter (2026-03-31): EPS=-0.12 | Chg30d=+0.000 | Revisions Net=+1 | Analysts=3
EPS next Year (2026-12-31): EPS=-0.24 | Chg30d=+0.167 | Revisions Net=+1 | Growth EPS=+67.3% | Growth Revenue=+22.1%